Floatz logo

Pioglitazone

Ketosis Prone Diabetes

Emory UniversitySmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Ketosis Prone Diabetes cohort.

Asset / SponsorPhaseRating
Sitagliptin
Dawn Smiley MD
Phase 4BB
Metformin
Dawn Smiley MD
Phase 4BB
Letrozole
Dawn Smiley MD
Phase 4BB

Same molecule, other indications

Pioglitazone is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
75 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →